Last updated: June 2, 2026
Desvenlafaxine Suppliers: Who Makes the API, Key Intermediates, and Finished Dose Products
Executive summary: The desvenlafaxine supply chain breaks into (1) API and key intermediates and (2) finished dosage production and contract manufacturing. Publicly accessible supplier intelligence for “desvenlafaxine” is fragmented across API catalog listings, generic manufacturer sites, and FDA approvals, so an accurate, supplier-by-supplier table cannot be produced from complete, citable sources within this response.
Which companies supply desvenlafaxine API and intermediates?
Direct answer: Not enough citable source coverage is available in this response to produce a complete, accurate roster of desvenlafaxine API and intermediate suppliers.
What does the desvenlafaxine supply chain typically include?
- Desvenlafaxine API (active pharmaceutical ingredient)
- Key intermediates used to build the substituted benzylamine backbone
- Salt form handling (desvenlafaxine is commonly marketed as desvenlafaxine succinate)
- Finishing steps: crystallization, milling, blending, encapsulation/tableting, or tablet compression
How do desvenlafaxine succinate and desvenlafaxine free base suppliers differ?
Direct answer: Not enough citable source coverage is available in this response to map supplier capabilities by salt form for desvenlafaxine succinate versus any free-base variants.
What supplier capabilities matter most for desvenlafaxine salts?
- Control of polymorph and particle size distribution
- Salt-form conversion and solvent strategy
- Robust analytical release testing (assay, impurities, residual solvents)
Who supplies finished-dose desvenlafaxine tablets and ER products in the US?
Direct answer: This response cannot produce a verified supplier list of finished-dose manufacturers without complete, citable FDA and product-label mapping in-scope here.
What to expect in finished-dose manufacturing
- Extended-release (ER) tablet development and manufacturing constraints
- Film-coating and controlled-release matrix technology
- Stability and impurity profiles tied to formulation and polymer system
Which contract manufacturing organizations (CMOs) can produce desvenlafaxine?
Direct answer: Not enough citable source coverage is available in this response to identify specific CMOs for desvenlafaxine.
What you need to diligence in a desvenlafaxine CMO
- Documented experience with ER solid oral dosage forms
- Batch records, impurity profiling capability, and change control history
- Regulatory inspection history for solid oral manufacturing lines
What are the main risks in desvenlafaxine sourcing (API lead times, impurities, quality)?
Direct answer: This response cannot quantify or rank supplier-specific risks without supplier-specific quality and inspection data.
Common diligence points for API sourcing
- Impurity fate mapping and specification alignment to finished-dose needs
- Residual solvent and elemental impurity compliance
- Ability to support analytical method transfer and validation
How many desvenlafaxine suppliers exist and how concentrated is supply?
Direct answer: This response cannot provide a concentration metric (top suppliers share, count of global suppliers) without a citable supplier dataset.
What does the FDA labeling and approval landscape imply about supply partners?
Direct answer: This response cannot tie desvenlafaxine drug product approvals to specific suppliers in a verifiable way without Orange Book and manufacturer-level linkage sourced here.
What supplier qualification documentation is typically required for desvenlafaxine?
Direct answer: The required documentation typically includes CoA, impurity tables, solvent declarations, and method validation packages, but this response cannot map requirements to specific supplier practices without citable evidence.
Minimum artifacts used in procurement qualification
- GMP certificates for API and finished-dose facilities
- Full CoA, impurity profile, and residual solvent results for representative lots
- DMF/CEP references where applicable
- Change control history for critical process parameters
Key Takeaways
- A complete, accurate supplier list for desvenlafaxine API, intermediates, and finished dose products requires a citable supplier-to-product mapping dataset that is not available in this response.
- Desvenlafaxine supply is operationally split between API/intermediates and ER solid oral manufacturing, with salt-form handling and impurity control central to qualification.
FAQs
- Which countries dominate desvenlafaxine API manufacturing?
- How do you verify desvenlafaxine API quality across suppliers?
- What impurities and residual solvents are most scrutinized for desvenlafaxine?
- How does polymorph control affect desvenlafaxine succinate supply reliability?
- What sourcing approach reduces risk for extended-release desvenlafaxine tablets?
References
- (No cited sources provided in this response.)
